Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fidia Spa ( (IT:FDA) ) has shared an update.
Fidia S.p.A. announced the conversion of five bonds into 200,000 new shares at a price of Euro 0.25 per share, as part of a convertible bond loan with warrants. This conversion increases the company’s share capital by Euro 50,000, bringing the total to Euro 7,297,761.90 and the total number of shares to 12,652,385. The move is part of a strategic capital increase plan to support the company’s growth and enhance its market position.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., headquartered in San Mauro Torinese, is a global leader in the design, production, and marketing of high-performance integrated milling systems. The company primarily serves the automotive and aerospace sectors, offering comprehensive solutions for the entire milling process. With over 40 years of experience, Fidia is recognized for its expertise in numerical controls, high-speed milling systems, and CAM software for complex shapes.
YTD Price Performance: -93.51%
Average Trading Volume: 416,648
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2.24M
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.